The Doctor’s Advocate | Third Quarter 2022
The Back Page

Industry and Company News

Megan Mahoney, MD, MBA, Appointed to Board of Governors

We are pleased to announce the appointment of Megan Mahoney, MD, MBA, to the Board of Governors. Dr. Mahoney is Chief of Staff for Stanford Health Care and Professor of Medicine at Stanford University School of Medicine. In this role, she oversees the quality, safety, and professionalism activities of the 3,000 physicians within Stanford Health Care.

Dr. Mahoney is known for her passion for both teams and technology in healthcare. She is leading initiatives in team-based healthcare and precision health. The initiatives bring together the latest science and technology to enhance the understanding of each patient, from lifestyle to DNA, and customize their healthcare on an individual basis.

“We are pleased to welcome Dr. Mahoney to our board,” said Richard E. Anderson, MD, FACP, Chairman and CEO of The Doctors Company and TDC Group. “Her background is extraordinary, and her expertise in precision health and practice transformation, in large healthcare systems, further strengthens The Doctors Company on our mission to advance the practice of good medicine.”

Before joining Stanford, Dr. Mahoney served in leadership capacities in clinic operations, medical education, and research as a faculty member at the University of California, San Francisco, for 10 years. She was a Visiting Professor at Aga Khan Medical College of East Africa and served on the family medicine committee of the Kenya Ministry of Health. In addition, she was selected as one of the Top 100 Women Leaders in Medicine of 2021 by Women We Admire.

Launching a New APC Product

Our nationwide perspective positions us to identify trends in healthcare delivery and respond with innovative and essential products and services that meet the needs of the care providers on the frontlines of those trends. One such trend is the increase of advanced practice clinicians (APCs) providing primary care in the face of a growing national physician shortage. In response, we are expanding our products and services to offer a new product developed specifically for APCs.

Our new product supports the delivery of care by APCs by providing outstanding medical malpractice insurance, risk management and patient safety information, educational resources and continuing education, and practice management solutions. It does not compromise our ability or commitment to deliver industry-leading services to physicians across the spectrum of care.

As a company founded and led by doctors, The Doctors Company has been relentlessly advancing, protecting, and rewarding the practice of good medicine for more than 45 years. We have always been there to support doctors with expert guidance, resources, and coverage—and we always will. We stand by our members with strong defense, the Tribute® Plan—the industry’s largest financial award—and the best imaginable service.

Sign Up for Automatic Updates

Join our subscriber list to get the latest information on patient safety topics and emerging medical trends.

The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.

The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.

The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.

The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.